K Beiske

Author PubWeight™ 37.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001 3.55
2 Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1999 1.83
3 The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc Natl Acad Sci U S A 1985 1.34
4 Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol 1998 1.23
5 TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995 1.16
6 Characterization of human mononuclear cells after positive selection with immunomagnetic particles. Scand J Immunol 1986 1.11
7 Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer 2011 1.09
8 Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol 1989 1.04
9 Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res 1987 1.02
10 Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol 2008 1.02
11 Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 1998 1.01
12 A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood 2000 1.00
13 Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer 2013 0.95
14 Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl 1991 0.94
15 T-zone lymphoma with predominance of 'plasmacytoid T-cells' associated with myelomonocytic leukaemia--a distinct clinicopathological entity. J Pathol 1986 0.94
16 Single cell studies on the immunological marker profile of plasmacytoid T-zone cells. Lab Invest 1987 0.92
17 Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma. Int J Cancer 1989 0.91
18 Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia. Histopathology 2007 0.90
19 Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 1997 0.89
20 Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol 1987 0.86
21 Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens. Eur J Immunol 1989 0.84
22 Regulation of c-myc transcription and protein expression during activation of normal human B cells. Exp Cell Res 1987 0.84
23 Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells. J Immunol 1987 0.83
24 Different responses elicited in vitro by antibodies to IgM and IgD in cells from a surface IgM + D-positive human follicular lymphoma. Scand J Immunol 1983 0.83
25 Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes. Eur J Immunol 1992 0.81
26 Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia. Clin Exp Immunol 2006 0.80
27 Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood 2001 0.80
28 Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias. Blood 1991 0.79
29 Can morphology predict 1p/19q loss in oligodendroglial tumours? Histopathology 2008 0.79
30 Immunohistological diagnosis of "plasmacytoid T cell lymphoma" in paraffin wax sections. J Clin Pathol 1991 0.79
31 Antigen-presenting function of human peritoneum mesothelial cells isolated from a pancreatic carcinoma patient after mutant Ras peptide vaccination. Cancer Immunol Immunother 1996 0.78
32 Different fate of antibodies to surface IgM and IgD in germinal centre cell-associated lymphomas. Scand J Immunol 1984 0.78
33 CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton. Eur J Immunol 1997 0.77
34 Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation. Clin Exp Immunol 2009 0.77
35 Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation. J Natl Cancer Inst 1988 0.77
36 Purging of tumor cells from leukapheresis products: experimental and clinical aspects. J Hematother 1996 0.77
37 An effective immunomagnetic method for bone marrow purging in T cell malignancies. Bone Marrow Transplant 1992 0.76
38 Induction of maturation of human B-cell lymphomas in vitro. Morphologic changes in relation to immunoglobulin and DNA synthesis. Am J Pathol 1984 0.75
39 [Monoclonal antibodies. A new tool in the diagnosis of leukemia and lymphoma]. Tidsskr Nor Laegeforen 1985 0.75
40 T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases. Blood 1991 0.75
41 [High-dose therapy of cancer with CD34 positive cells as stem cell support]. Tidsskr Nor Laegeforen 1996 0.75
42 [Immunophenotyping of leukemias]. Tidsskr Nor Laegeforen 1992 0.75
43 Chromomycosis: a report of three cases from Ethiopia. Ethiop Med J 1981 0.75
44 [Non-Hodgkin's lymphoma of T cell type in the intestine in a patient with celiac disease and ulcerative jejunitis. An example of the diagnostic value of DNA probes]. Tidsskr Nor Laegeforen 1988 0.75
45 Co-induction of Mad1 and c-Myc in activated normal B lymphocytes. Scand J Immunol 2000 0.75
46 [Giant cell anaplastic anemia]. Tidsskr Nor Laegeforen 1989 0.75
47 [Human T-cell lymphotrophic virus type I and T-cell lymphoma]. Tidsskr Nor Laegeforen 1996 0.75
48 Immunological typing of acute leukaemias by rosetting with immunomagnetic beads: comparison with immunofluorescence staining. Scand J Immunol 1990 0.75
49 Regulation of c-myc mRNA and protein levels during activation of normal human B cells. Curr Top Microbiol Immunol 1986 0.75
50 Immunological typing of acute leukemias: immunoenzymatic staining of fixed cells compared with immunofluorescence staining of unfixed cells in suspension. Eur J Haematol 1988 0.75
51 Induction of maturation in different types of B-cell lymphomas in vitro with TPA and antibodies to surface immunoglobulin. Scand J Immunol 1984 0.75
52 Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads. Prog Clin Biol Res 1994 0.75
53 High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma. Bone Marrow Transplant 1999 0.75
54 [Ulcerative herpes esophagitis]. Tidsskr Nor Laegeforen 1981 0.75
55 Rhinosporidiosis affecting the palpebral conjunctiva: a case report. Ethiop Med J 1982 0.75